Literature DB >> 158060

The induction of hapten-specific immunological tolerance and immunity in B lymphocytes. VI. Differential tolerance susceptibility in adult spleen as a function of B-cell maturation level.

J M Fidler.   

Abstract

The maturation level of the B-lymphocyte subpopulations involved in trinitrophenyl (TNP)-specific immunological tolerance in adult mice induced by the injection of trinitrobenzenesulfonic acid (TNBS) was investigated using in vitro antigen-specific and nonspecific polyclonal stimulation. The maturity of the B-cell subsets being studied was defined by the antigen or polyclonal activator which evoked a response. Thus, the thymic independent (TI-1) antigen TNP-lipopolysaccharide (TNP-LPS) and the polyclonal stimulant LPS were used to activate immature, neonatal-type B lymphocytes, whereas mature, adult-type B cells were responsive to the TI-2 antigen, TNP-Ficoll, and the nonspecific activator, purified protein derivative (PPD). Whereas unresponsiveness in TNP-LPS-reactive (immature) B cells 4 d after TNBS treatment was previously shown to be the result of functional deletion, partially reversible receptor blockade was detected in this study early after tolerogen treatment. By the 24-h point, tolerance was irreversible, as assessed by 24-h of antigen-free incubation and cocultivation of tolerant cells with control splenocytes. Tolerance was induced more rapidly in immature, TI-1 B cells than in mature TI-2 B lymphocytes. B lymphocytes reactive to TNP-Ficoll were also less susceptible to receptor blockade. Using LPS as a nonspecific probe for immature B cells, 60% tolerance in high affinity TNP-specific cells was induced within 12 h of TNBS treatment, and complete unresponsiveness by 24 h. In contrast, no significant decrease in response to the mature B-cell activator, PPD, occurred until day 2. Furthermore, the 50% tolerance level was achieved in TNP-specific LPS-reactive B cells by 100 times less tolerogen than required for PPD-responsive cells. Thus, TNBS-induced unresponsiveness in cells reactive to TNP-LPS is initially a result of reversible receptor blockade which leads within 4 d to functional deletion. Immature, TI-1 B lymphocytes, which give polyclonal responses to LPS and antigen-specific responses to TNP-LPS, are rendered tolerant to TNBS more rapidly and at lower tolerogen does than mature, TI-2 mouse B cells which react polyclonally to PPD and specifically to TNP-Ficoll. Moreover, these data show that both the immature and the mature B lymphocyts with these characteristic tolerance susceptibilities and specific and nonspecific immune response patterns are present in the adult mouse spleen.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 158060      PMCID: PMC2185647          DOI: 10.1084/jem.150.3.491

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  50 in total

1.  Immunoglobulin-receptors revisited.

Authors:  E S Vitetta; J W Uhr
Journal:  Science       Date:  1975-09-19       Impact factor: 47.728

2.  Receptor-mediated inactivation of early B lymphocytes.

Authors:  C L Sidman; E R Unanue
Journal:  Nature       Date:  1975-09-11       Impact factor: 49.962

3.  The self-nonself discrimination: A one-signal mechanism.

Authors:  A Coutinho; G Möller
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

4.  B lymphocyte differentiation induced by lipopolysaccharide. III. Suppression of B cell maturation by anti-mouse immunoglobulin antibodies.

Authors:  J F Kearney; M D Cooper; A R Lawton
Journal:  J Immunol       Date:  1976-06       Impact factor: 5.422

5.  Hapten-induced B cell paralysis. II. Evidence for trivial mechanisms of tolerance.

Authors:  E Gronowicz; A Coutinho
Journal:  Eur J Immunol       Date:  1976-06       Impact factor: 5.532

6.  Ontogeny of mouse B lymphocytes and inactivation by antigen of early B lymphocytes.

Authors:  C Bruyns; G Urbain-Vansanten; C Planard; C Vos-Cloetens; J Urbain
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

7.  Thymus-independent antigens: the preparation of covalent, hapten-ficoll conjugates.

Authors:  J K Inman
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

8.  Ontogeny of mouse lymphocyte function. II. Development of the ability to produce antibody is modulated by T lymphocytes.

Authors:  D E Mosier; B M Johnson
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

9.  Differential susceptibility of neonatal and adult murine spleen cells to in vitro induction of B-cell tolerance.

Authors:  J C Cambier; J R Kettman; E S Vitetta; J W Uhr
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

10.  Abnormal ratio of membrane immunoglobulin classes in mice with an X-linked B-lymphocyte defect.

Authors:  F D Finkelman; A H Smith; I Scher; W E Paul
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Innate response activator B cells: origins and functions.

Authors:  Benjamin G Chousterman; Filip K Swirski
Journal:  Int Immunol       Date:  2015-05-08       Impact factor: 4.823

Review 2.  Current perspectives on the cellular mechanisms of immunologic tolerance.

Authors:  D E Parks; W O Weigle
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

3.  CEACAM1 regulates the IL-6 mediated fever response to LPS through the RP105 receptor in murine monocytes.

Authors:  Zhifang Zhang; Deirdre La Placa; Tung Nguyen; Maciej Kujawski; Keith Le; Lin Li; John E Shively
Journal:  BMC Immunol       Date:  2019-01-23       Impact factor: 3.615

4.  Late clonal selection and expansion of the TEPC-15 germ-line specificity.

Authors:  J Fung; H Köhler
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

5.  Definition of conditions that enable antigen-specific activation of the majority of isolated trinitrophenol-binding B cells.

Authors:  J C Cambier; J G Monroe; M J Neale
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.